发明公开
EP3296747A1 NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
有权
非酒石酸脂肪肝（NAFLD）和非酒石酸性肝炎（NASH）生物标志物及其用途
- 专利标题： NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NONALCOHOLIC STEATOHEPATITIS (NASH) BIOMARKERS AND USES THEREOF
- 专利标题（中）： 非酒石酸脂肪肝（NAFLD）和非酒石酸性肝炎（NASH）生物标志物及其用途
-
申请号： EP17197260.7申请日： 2014-03-10
-
公开(公告)号： EP3296747A1公开(公告)日： 2018-03-21
- 发明人: NIKRAD, Malti , FIELD, Stuart G. , WILLIAMS, Stephen Alaric
- 申请人： Somalogic, Inc.
- 申请人地址： 2945 Wilderness Place Boulder, CO 80301 US
- 专利权人： Somalogic, Inc.
- 当前专利权人： Somalogic, Inc.
- 当前专利权人地址： 2945 Wilderness Place Boulder, CO 80301 US
- 代理机构： Salisbury, Frances
- 优先权： US201361787967P 20130315
- 主分类号： G01N33/68
- IPC分类号： G01N33/68
摘要：
Methods, compositions, and kits for determining whether a subject has non-alcoholic fatty liver disease (NAFLD) are provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatosis are also provided. Methods, compositions, and kits for determining whether a subject has non-alcoholic steatohepatitis (NASH) are also provided.
公开/授权文献
信息查询
IPC分类:
